Occlusions Prompt CABG Medical To Halt Holly Graft Trial
This article was originally published in The Gray Sheet
Executive Summary
CABG Medical will spend $6 mil. to $8 mil. in 2006 in an attempt to put development of the Holly Graft (HGS) drug-eluting coronary bypass system back on track